Difference between revisions of "Antithrombin III (human and recombinant)"
Warner-admin (talk | contribs) m (Text replacement - " " to " ") |
Warner-admin (talk | contribs) m (Text replacement - "[http://online.lexi.com/ Lexicomp]" to "[https://online.lexi.com/lco/action/login UpToDate Lexidrug]") |
||
| Line 6: | Line 6: | ||
<br>Extravasation: no information | <br>Extravasation: no information | ||
| − | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [ | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://reference.medscape.com/drug/thrombate-iii-antithrombin-iii-342868 medscape], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref><ref name="atryn"></ref> |
==Patient drug information== | ==Patient drug information== | ||
Revision as of 01:29, 27 June 2024
General information
Class/mechanism: Inhibitor of thrombin, which converts fibrinogen to fibrin in the coagulation cascade and subsequent development of thrombus. Clinical applications include management of patients with hereditary antithrombin III (AT-III) deficiency. Please choose from the products below to find specific drug/manufacturer information:
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, UpToDate Lexidrug, medscape, UpToDate (courtesy of Lexicomp), or the prescribing information.[2][5]
Patient drug information
- Antithrombin III (human and recombinant) patient drug information (UpToDate)[7]
- Brief patient counseling information can be found on page 15 of the ATryn package insert[5]
Also known as
- Brand names: ATryn, Thrombate III
References
- ↑ Thrombate III manufacturer's website
- ↑ 2.0 2.1 Antithrombin III, human (Thrombate III) package insert
- ↑ File:Antithrombiniii.pdf
- ↑ ATryn manufacturer's website
- ↑ 5.0 5.1 5.2 Antithrombin III, recombinant (ATryn) package insert
- ↑ File:Antithrombiniiiatryn.pdf
- ↑ Antithrombin III (human and recombinant) patient drug information (UpToDate)